A Bioartificial organ is a designed device or tissue which is consolidated into human body to supplant a characteristic organ .It joins biomaterials and natural cells for completely substitution of patient disappointment organs. Example of bioartificial organ are bioartificial kidney device, joining biomaterials and kidney epithelial cells for enhanced blood detoxification, bioartificial pancreas device, consolidating exemplification of pancreatic cells for treatment of diabetes, bioartificial lungs for considering lung recovery.

Track 02- Cord Blood Stem Cells and Regenerative Medicine

Recently, cord blood stems cells are developed in the treatment of different diseases, including a broad range of cancers, blood disorders, and genetic diseases. In a cord blood transplant, stem cells are infused in to a patient’s bloodstream for healing and repairing damaged cells and tissue. In a successful transplant, new healthy immune system has been created. The natural power and purity of newborn's cord blood are responsible for healthy development during gestation. Cord blood applications have developed beyond transplant medicine into the areas of regenerative medicine including brain injuries, autism, Cardiac Problems, and Autoimmune Deficiencies. The latest research in routine transplantation of cord blood are reviewed followed by the critical role of cord blood stem cells in regenerative medicine research and novel approaches using cord blood as a source of whole blood for transfusion.

Track 03- Bone and Cartilage Tissue Engineering

This interdisciplinary engineering has attracted much attention as a new therapeutic means that may overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for organ transplantation with soft tissues. Although significant progress has been made in the tissue engineering field, many challenges remain and further development in this area will require on-going interactions and collaborations among the scientists from multiple disciplines, and in partnership with the regulatory and the funding agencies. As a result of the medical and market potential, there is significant academic and corporate interest in this technology.

Track 04- Stem cells to Battle cancer

Stem cell transplant is treatment in some types of cancers like leukemia, multiple myeloma, or some types of lymphoma. Stem cell transplantation is the procedure that restores blood-forming stem cells in patients who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers.

Track 05- Novel Approaches guided in Tissue Engineering

GTR are dental surgical procedures that use barrier membranes to direct the growth of new bone and gingival tissue at sites with insufficient volumes or dimensions of bone or gingiva for proper function, esthetics or prosthetic restoration.

Track 06- Clinical Medicine and Scaffolds

Clinical medicine relates to medicine field that deals mainly with the study and practice of medicine based on the direct examination of the patient. In clinical medicine, medical practitioners assess patients in order to diagnose, treat, and prevent disease.

Scaffolds are one of the three most important essentials constituting the basic concept of Regenerative Medicine, and are included in the core technology of Regenerative Medicine. Every day thousands of surgical procedures are done to replace or repair tissue that has been damaged through disease or trauma. The developing field of tissue engineering (TE) aims to regenerate damaged tissues by combining cells from the body with highly porous scaffold biomaterials, which act as templates for tissue regeneration, to guide the growth of new tissue. Scaffolds has a prominent role in tissue regeneration the designs, fabrication, 3D models, surface ligands and molecular architecture, nanoparticle-cell interactions and porous of the scaffolds are been used in the field in attempts to regenerate different tissues and organs in the body. The world stem cell market was approximately 2.715 billion dollars in 2010, and with a growth rate of 16.8% annually, a market of 6.877 billion dollars will be formed in 2016. From 2017, the expected annual growth rate is 10.6%, which would expand the market to 11.38 billion dollars by 2021.

Track 07- Clinical trials with Stem Cells

Stem cell treatments and clinical trials have been going on for over 40 years; however we are still in the initial stages of stem cell therapy being utilized as an effective alternative treatment method to traditional pharmaceutical based treatments. Much of the early work in stem cell clinical trials focused on the overall effectiveness and safety of the procedures involved. The primary concern with any new treatment is the long term safety and standardization of results. There have been countless journals and research papers focusing in on these clinical trials that have revealed promising results from these initial trials around the world

Track 08- Biomaterials & Bioengineering

Biomaterials are being utilized for the social insurance applications from old circumstances. In any case, consequent development has made them more flexible and has expanded their utility. Biomaterials have reformed the territories like bioengineering and tissue designing for the advancement of novel methodologies to battle perilous infections. Together with biomaterials, immature microorganism innovation is additionally being utilized to enhance the current human services offices. These ideas and innovations are being utilized for the treatment of various maladies like cardiovascular disappointment, cracks, profound skin wounds, and so forth. Presentation of nanomaterial’s then again is turning into a major seek after a superior and a reasonable social insurance. Mechanical headways are in progress for the advancement of persistent observing and controlling glucose levels by the implantation of sensor chips.

Track 09: Soft Tissue Replacement

In soft tissue implants, as in other applications that involve engineering, the performance of an implanted device depends upon both the materials used and the design of the device or implant. The initial selection of material should be based on sound materials engineering practice. The final judgment on the suitability of a material depends upon observation of the in-vivo clinical performance of the implant. Such observations may require many years or decades. This requirement of in-vivo observation represents one of the major problems in the selection of appropriate materials for use in the human body. Another problem is that the performance of an implant may also depend on the design rather than the materials themselves. Even though one may have an ideal material and design, the actual performance also greatly depends on the skill of the surgeons and the prior condition of patients.

Track 10: Regenerative Rehabilitation

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function".This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.

Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself. When the cell source for a regenerated organ is derived from the patient's own tissue or cells, the challenge of organ transplant rejection via immunological mismatch is circumvented. This approach could alleviate the problem of the shortage of organs available for donation.

Track 11: Tissue Repair and Regeneration

Deregulation of normal tissue repair has dramatic consequences for life quality and survival of patients. Together, insufficient healing (chronic wounds) and excessive repair after injury (scarring/fibrosis) cause healthcare costs reaching tens of billions of dollars per year in the US alone. Chronic and fibrotic healing occurs when the body’s own repair capacity is either impaired or overwhelmed. One approach in regenerative medicine is to replace injured, diseased or aged tissues with functional tissue equivalents. This approach is challenged by adverse host reactions that are part of the body repair program, e.g., immune, inflammatory, and fibrotic responses. Thus, regenerative medicine increasingly considers to support the adult's body's own regenerative capacities to promote closure of wounds that never heal and to keep excessive repair at bay. However, it is still unclear why humans lost regenerative capacity during evolution, whereas lower organisms can regenerate whole organs.

Track 12: Bio Banking

Biobanks play a crucial role in biomedical research. The wide array of bio specimens (including blood, saliva, plasma, and purified DNA) maintained in biobanks can be described as libraries of the human organism. They are carefully characterized to determine the general and unique features of the continuous cell line and the absence or presence of contaminants, therefore establishing a fundamental understanding about the raw material from which the biological product is being derived and maintained. Biobanks catalogue specimens using genetic and other traits, such as age, gender, blood type, and ethnicity.

Track 13: Cellular and gene Therapies

Human cell therapy and gene therapy is the administration of cellular and genetic material to modify or manipulate the expression of a gene product or to alter the biological properties of living cells for therapeutic use. Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Gene therapies can work by several mechanisms: Replacing a disease-causing gene with a healthy copy of the gene, inactivating a disease-causing gene that is not functioning properly, introducing a new or modified gene into the body to help treat a disease.

Track 14: Biomedical Engineering Techniques

Biomedical engineering approaches to help aid in the detection and treatment of tropical diseases such as dengue, malaria, cholera, schistosomiasis, lymphatic filariasis, ebola, leprosy, leishmaniasis, and American trypanosomiasis (Chagas). Many different forms of non-invasive approaches such as ultrasound, echocardiography and electrocardiography, bioelectrical impedance, optical detection, simplified and rapid serological tests such as lab-on-chip and micro-/nano-fluidic platforms and medical support systems such as artificial intelligence clinical support systems are included in Biomedical Engineering Techniques.

Track15: Biomarkers

Biomarkers, in the hands of clinical investigators, provide a dynamic and powerful approach to understanding the spectrum of diseases with obvious applications in analytic epidemiology, biomarkers and clinical research in disease prevention, diagnosis and disease management. Biomarkers have the additional potential to identify individuals susceptible to particular diseases. This conference is a podium that brings and shares collective knowledge and research explorations in biomarkers study. In the recent years, the information about cancer biomarkers has increased largely providing a huge potential for improving the management of cancer patients by improving the accuracy of detection and efficacy of treatment. Latest technological advancements have enabled the examination of many possible biomarkers and renewed interest in developing new biomarkers. All such developments can be evidenced in this biomarker congress.

Track 16: Biochips & Tissue chips

Biochips refer to the complete fundamental functional unit, capable of performing multi biochemical tasks simultaneously. Tissue chips on the other hand are similar miniaturized units that can replace a tissue or some part of it, enabling the organ to work normally. Both biochips & tissue chips have been elemental in tissue engineering technology and have proven to be of utmost importance in the same arena. DNA microarray also called as biochip in simple terms consists of a two dimensional grid system where upon sensors or solid flat substrates are incorporated. These solid substrates can be either positively charged just like silicon or glass or can also be consisting of integrated circuitry units that perform best in signal transduction studies. These sorts of microarrays have application in micromechanical studies.

Track 17:Stem cell engineering

Stem cell engineering (SCE) was to gather information on the worldwide status and trends of research and development in field SCE, that is, the engineers and engineering approaches in the stem cell field, both in basic research and translation of research into clinical applications and commercial products. The study of Stem Cells Engineering is facilitated and managed by the World Technology Evaluation Center (WTEC). This will provide a support for the generation of future economic growth and new markets. The process involved site visits in both Europe and Asia, and it also included several different workshops.

Track18: Rejuvenation

Rejuvenation is a medical discipline focused on the practical reversal of the aging process. Rejuvenation is distinct from life extension. Life extension strategies often study the causes of aging and try to oppose those causes in order to slow aging. Rejuvenation is the reversal of aging and thus requires a different strategy, namely repair of the damage that is associated with aging or replacement of damaged tissue with new tissue. Rejuvenation can be a means of life extension, but most life extension strategies do not involve rejuvenation.

Cell immortalization and senescence

Pluripotent stem cells

DNA damage

Gene targeting

Track 19 :Biofabrication

Biofabrication research leads to the fabrication of advanced biological models, non-medical biological systems and medical therapeutic products. It is an automated production of organs and tissue that deals with health challenge in medicine. Biofabrication technology is a platform for a broad range of tissues such as nervous, cartilage, blood vessels and skin, as well as complete organs such as kidney, liver and the heart. It is used for 3D printing which is also known as the theory of additive manufacturing. Its main objective is to merge cells and fibres into an independent construct that can substitute wounded tissue.

Biochemical signaling

Additive manufacturing technologies

Limits of bone bio fabrication

Clinical translation

Stereo lithographic process

Laser sinterings

Validations

Biofabrication of Bone Tissue Engineering

Track 20:Grafts in Tissue Engineering

Grafting is a surgical procedure to move tissue from one site to another on the body, or from another creature, without bringing its own blood supply with it. Instead, a new blood supply grows in after it is placed. Different types of grafting contains skin grafting, bone grafting, vascular grafting and ligament repair. Skin grafting is most common used grafting technique. Wounds, burns and scars have been dealt with this efficiently. Bone transplantation is a bit difficult but well-known process to replace damaged bones. In Recent years cardiovascular disease are being combatted with the development of a tissue-engineered vascular graft (TEVG). The various approaches to generate TEVGs are scaffold-based methods and tissue self-assembly processes. The channels for vascular grafting are autologous arteries or veins. Synthetic vascular grafts are also available in the market nowadays.